Cargando…
Synthetic Toll-like Receptors 7 and 8 Agonists: Structure–Activity Relationship in the Oxoadenine Series
[Image: see text] Toll-like receptors 7 and 8 (TLR7/8) are broadly expressed on antigen-presenting cells, making TLR7/8 agonists likely candidates for the development of new vaccine adjuvants. We previously reported the synthesis of a new series of 8-oxoadenines substituted at the 9-position with a...
Autores principales: | Evans, Jay T., Bess, Laura S., Mwakwari, Sandra C., Livesay, Mark T., Li, Yufeng, Cybulski, Van, Johnson, David A., Bazin, Hélène G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761749/ https://www.ncbi.nlm.nih.gov/pubmed/31572869 http://dx.doi.org/10.1021/acsomega.9b02138 |
Ejemplares similares
-
Mutagenesis mechanism of the major oxidative adenine lesion 7,8-dihydro-8-oxoadenine
por: Koag, Myong-Chul, et al.
Publicado: (2020) -
Novel Lipidated Imidazoquinoline TLR7/8 Adjuvants Elicit Influenza-Specific Th1 Immune Responses and Protect Against Heterologous H3N2 Influenza Challenge in Mice
por: Miller, Shannon M., et al.
Publicado: (2020) -
DNA interstrand cross-links induced by the major oxidative adenine lesion 7,8-dihydro-8-oxoadenine
por: Rozelle, Aaron L., et al.
Publicado: (2021) -
7,8-dihydro-8-oxoadenine, a highly mutagenic adduct, is repaired by Escherichia coli and human mismatch-specific uracil/thymine-DNA glycosylases
por: Talhaoui, Ibtissam, et al.
Publicado: (2013) -
Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants
por: Bhagchandani, Sachin, et al.
Publicado: (2021)